Healogics   Report issue

Academic/Hospital Phase 2
Founded: Jacksonville FL United States (1996)

Organization Overview

First Clinical Trial
2015
NCT02682953
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (3)

oxygen (1 trial)

plerixafor (mozobil) (1 trial)

sargramostim (leukine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Multiple Myeloma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 3